title: Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohort.
abstract: Experimental evidence shows cross-talk in mammary cells between estrogen, insulin-like growth factor I (IGF-I) and their respective receptors and possible synergistic effects of estrogen receptor (ER) activation and increased IGF-I signaling with regard to breast tumor development, and epidemiological evidence suggests that circulating IGF-I levels may be related more to the risk of ER-positive than ER-negative breast cancer. Using a case-control study nested within the prospective European EPIC cohort (938 breast cancer cases and 1,394 matched control subjects), we analyzed the relationships of prediagnostic serum IGF-I levels with the risk of estrogen and progesterone receptor-positive and -negative breast tumors. IGF-I levels were positively associated with the risk of ER+ breast tumors overall (pre- and postmenopausal women combined, odds ratio (OR)Q4-Q1 = 1.41 [95% confidence interval (CI) 1.01-1.98] for the highest vs. lowest quartile; OR = 1.17 [95% CI 1.04-1.33] per 1-standard deviation (SD) increase in IGF-I, ptrend = 0.01) and among women who were diagnosed with breast cancer at 50 years or older (ORQ3-Q1 = 1.38 [95% CI 1.01-1.89]; OR = 1.19 [95% CI 1.04-1.36] per 1-SD increase in IGF-I, ptrend = 0.01) but not with receptor-positive disease diagnosed at an earlier age. No statistically significant associations were observed for ER- breast tumors overall and by age at diagnosis. Tests for heterogeneity by receptor status of the tumor were not statistically significant, except for women diagnosed with breast cancer at 50 years or older (phet = 0.03 for ER+/PR+ vs. ER-/PR- disease). Our data add to a global body of evidence indicating that higher circulating IGF-I levels may increase risk specifically of receptor-positive, but not receptor-negative, breast cancer diagnosed at 50 years or older.
authors.affiliation: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ) Heidelberg, Germany.
authors.forename: Rudolf
authors.initials: R
authors.lastname: Kaaks
authors.forename: Theron
authors.initials: T
authors.lastname: Johnson
authors.forename: Kaja
authors.initials: K
authors.lastname: Tikk
authors.forename: Disorn
authors.initials: D
authors.lastname: Sookthai
authors.forename: Anne
authors.initials: A
authors.lastname: Tjønneland
authors.forename: Nina
authors.initials: N
authors.lastname: Roswall
authors.forename: Kim
authors.initials: K
authors.lastname: Overvad
authors.forename: Françoise
authors.initials: F
authors.lastname: Clavel-Chapelon
authors.forename: Marie-Christine
authors.initials: MC
authors.lastname: Boutron-Ruault
authors.forename: Laure
authors.initials: L
authors.lastname: Dossus
authors.forename: Sabina
authors.initials: S
authors.lastname: Rinaldi
authors.forename: Isabelle
authors.initials: I
authors.lastname: Romieu
authors.forename: Heiner
authors.initials: H
authors.lastname: Boeing
authors.forename: Madlen
authors.initials: M
authors.lastname: Schütze
authors.forename: Antonia
authors.initials: A
authors.lastname: Trichopoulou
authors.forename: Pagona
authors.initials: P
authors.lastname: Lagiou
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Trichopoulos
authors.forename: Domenico
authors.initials: D
authors.lastname: Palli
authors.forename: Sara
authors.initials: S
authors.lastname: Grioni
authors.forename: Rosario
authors.initials: R
authors.lastname: Tumino
authors.forename: Carlotta
authors.initials: C
authors.lastname: Sacerdote
authors.forename: Salvatore
authors.initials: S
authors.lastname: Panico
authors.forename: Genevieve
authors.initials: G
authors.lastname: Buckland
authors.forename: Marcial
authors.initials: M
authors.lastname: Argüelles
authors.forename: María-José
authors.initials: MJ
authors.lastname: Sánchez
authors.forename: Pilar
authors.initials: P
authors.lastname: Amiano
authors.forename: Maria-Dolores
authors.initials: MD
authors.lastname: Chirlaque
authors.forename: Eva
authors.initials: E
authors.lastname: Ardanaz
authors.forename: H Bas
authors.initials: HB
authors.lastname: Bueno-de-Mesquita
authors.forename: Carla H
authors.initials: CH
authors.lastname: van Gils
authors.forename: Petra H
authors.initials: PH
authors.lastname: Peeters
authors.forename: Anne
authors.initials: A
authors.lastname: Andersson
authors.forename: Malin
authors.initials: M
authors.lastname: Sund
authors.forename: Elisabete
authors.initials: E
authors.lastname: Weiderpass
authors.forename: Inger Torhild
authors.initials: IT
authors.lastname: Gram
authors.forename: Eiliv
authors.initials: E
authors.lastname: Lund
authors.forename: Kay-Tee
authors.initials: KT
authors.lastname: Khaw
authors.forename: Nick
authors.initials: N
authors.lastname: Wareham
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Key
authors.forename: Ruth C
authors.initials: RC
authors.lastname: Travis
authors.forename: Melissa A
authors.initials: MA
authors.lastname: Merritt
authors.forename: Marc J
authors.initials: MJ
authors.lastname: Gunter
authors.forename: Elio
authors.initials: E
authors.lastname: Riboli
authors.forename: Annekatrin
authors.initials: A
authors.lastname: Lukanova
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016022:Case-Control Studies; D004797:Enzyme-Linked Immunosorbent Assay; D047628:Estrogen Receptor alpha / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008593:Menopause; D008875:Middle Aged; D011379:Prognosis; D011446:Prospective Studies; D011980:Receptors, Progesterone / Q000097:blood*; D012307:Risk Factors
chemical_list: D014408:Biomarkers, Tumor; C506487:ESR1 protein, human; D047628:Estrogen Receptor alpha; D011980:Receptors, Progesterone; D007334:Insulin-Like Growth Factor I
keywords: European Prospective Investigation into Cancer and Nutrition; breast cancer; estrogen receptor; insulin-like growth factor I; prospective cohort